(Photo: Colonies of induced pluripotent stem cells)

Please Note:

Summit's Website is being edited to provide you with the most current information. 

Thank you for your patience.

Welcome. 

                          Summit for Stem Cell Foundation (Summit) is a 501(c)(3), volunteer organization dedicated to providing reliable information, education and support that can benefit people with Parkinson’s disease and other neurodegenerative conditions. Summit raises funds to support our programs:

 

  • Patient Services: 

    • Education   

    • Accurate & Reliable Information

    • Health & Resource Info

    • Support    

    • Information & updates about the autologous (DNA-matching )dopamine neuron replacement therapy for Parkinson's disease on a hastened path towards FDA approved Clinical Trials.

    • And an upcoming program: Financial Aid for Clinical Trials.

  • Educational Program: 

    • Webinar Series

    • C.M.E. (Continuing Medical Education) courses. 

    • Reliable & current information about regenerative medicine,          stem cells, research, Parkinson's disease                                              & other neurodegenerative conditions. 

  • Research & Science Program:

    • Support & grants for innovative, evidence-based regenerative

             medical research looking at “old” questions with a new vision.

Summit is a charitable organization that is dependent on and grateful for your generous contributions. 

​                                       Summit for Stem Cell Foundation’s mission is to support, educate and raise awareness about the development of today’s and tomorrow’s evidence-based regenerative medical therapies focused on Parkinson’s disease and other neurodegenerative disorders. It is our goal to empower patients and physicians with information to elevate their understanding in order to manage their care.

Our Mission:
Our Vision:
Hot Topics
Quick Links to
Prop 14 Summit Webinar flyer.png

Registration now OPEN.

Click on image for information & registration

Get the latest SCOOP!

Information on

Parkinson's disease, Research,

Medications, Researchers, Scientists, Interesting News

From Benjamin Stecher

Summit Collaborator

COVID-19
Adapting to the New Norm and Breathing Easier
 PDF Download
2020-05-22 (11).png

 

VIEW LATEST ISSUE

DOWNLOAD

SUBSCRIBE

 Summit Sentinel  or visit

Newsletter 

Archive

Click HERE

                                 Summit for Stem Cell Foundation's vision is a world where regenerative medicine is fully integrated into mainstream healthcare for persons with Parkinson’s disease and other neurological conditions as a treatment option.

                                                    to join us in our efforts to be of service to 7-10 million worldwide struggling with Parkinson's disease and other neurodegenerative conditions.  

We invite you
  • Summit supports the field of regenerative medicine that, we believe, is the best option to thoroughly integrate and address the needs of the human nervous system.

  • Any regenerative medical research we support MUST be science-based and evidence-based. We only support work either with FDA-approval or working towards FDA-approval.

  • Summit is working diligently for the benefit of persons struggling with Parkinson's disease and/or other neurodegenerative disorders and their caregivers around the globe.

Note:

Late 2018, Summit successfully supported, promoted and launched an autologous (DNA-matching) non-embryonic stem cell-based therapy for Parkinson’s disease (PD) research project. The research project is now on a hastened path to FDA approved clinical trials estimated to begin      

approximately towards the end of 2021.

 

Summit, having launched a highly anticipated cell-based therapy towards FDA-approval in the hopes of addressing the symptoms of PD, remains keenly aware that the long-standing questions about Parkinson's disease still remain:

  •  What is the CAUSE?

  •  What is the CURE?

 

Summit is committed to the search for these answers.

(Dopamine Neurons created from iPSC's)